ALZpath-Powered Blood Test Enables Landmark Study on Growing Alzheimer's Disease Prevalence
PR Newswire —
First Study to Use a pTau217 Blood Test to Detect Alzheimer's Disease Early and at Scale CARLSBAD, Calif., Dec. 17, 2025 /PRNewswire/ -- ALZpath, Inc., a leading developer of innovative diagnostic tools for Alzheimer's and related diseases, today announced that the Simoa® ALZpath pTau217...